Question 1

What does Cubist Pharmaceuticals do?

Accepted Answer

Cubist Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the research, development, and commercialization of

Question 2

In what sectors does Cubist Pharmaceuticals operate?

Accepted Answer

Cubist Pharmaceuticals operates in Biotechnology, Medical.

Question 3

How many companies has Cubist Pharmaceuticals acquired?

Accepted Answer

Cubist Pharmaceuticals has made 5 acquisitions between 2007-2013, with a total disclosed deal value of $1.6B.

Question 4

What companies are owned by Cubist Pharmaceuticals?

Accepted Answer

Companies acquired by Cubist Pharmaceuticals include Trius Therapeutics, Optimer Pharmaceuticals, Adolor, Calixa Therapeutics, Illumigen Biosciences.

Question 5

What are Cubist Pharmaceuticals's major acquisitions?

Accepted Answer

Cubist Pharmaceuticals's largest acquisitions include Trius Therapeutics ($704.0M, 2013), Optimer Pharmaceuticals ($535.0M, 2013), Adolor ($221.0M, 2011), Calixa Therapeutics ($92.5M, 2009).

Question 6

What is Cubist Pharmaceuticals's largest acquisition?

Accepted Answer

Cubist Pharmaceuticals's largest disclosed acquisition is Trius Therapeutics for $704.0M (2013).

Question 7

What was Cubist Pharmaceuticals's first acquisition?

Accepted Answer

Cubist Pharmaceuticals's first recorded acquisition was Illumigen Biosciences in 2007.

Question 8

What was Cubist Pharmaceuticals's most recent acquisition?

Accepted Answer

Cubist Pharmaceuticals's most recent acquisition is Trius Therapeutics, announced July 2013 for $704.0M.

Question 9

What is the average deal size for Cubist Pharmaceuticals acquisitions?

Accepted Answer

The average disclosed deal size for Cubist Pharmaceuticals acquisitions is $388.1M.

Question 10

What is the median deal size for Cubist Pharmaceuticals acquisitions?

Accepted Answer

The median disclosed deal size for Cubist Pharmaceuticals acquisitions is $378.0M. The median is often lower than the average because a few very large deals pull the average up.

Question 11

How much has Cubist Pharmaceuticals spent on acquisitions?

Accepted Answer

Cubist Pharmaceuticals has spent at least $1.6B across its disclosed acquisitions (of 5 total deals; some prices are undisclosed).

Question 12

Which sector has Cubist Pharmaceuticals spent the most on?

Accepted Answer

Cubist Pharmaceuticals has committed the most disclosed capital to Biotechnology companies — about $1.6B across its deals in that sector.

Question 13

What sectors does Cubist Pharmaceuticals usually acquire in?

Accepted Answer

Cubist Pharmaceuticals most frequently acquires companies in Biotechnology, Health Care, Pharmaceutical.

Question 14

In which sector has Cubist Pharmaceuticals made the most acquisitions?

Accepted Answer

Cubist Pharmaceuticals has made the most acquisitions in the Biotechnology sector.

Question 15

In which year did Cubist Pharmaceuticals make the most acquisitions?

Accepted Answer

Cubist Pharmaceuticals made the most acquisitions in 2013, with 2 deals.

Datasets

Top Companies

Top Industries

Years (1990-2026)

Cubist Pharmaceuticals

Company Details

Funding & Financials

IPO & Stock

Web Traffic

Technology & IP

Investor Activity

Company Info

Signals & Scores

Investments by Cubist Pharmaceuticals

Acquisitions by Cubist Pharmaceuticals

Key People at Cubist Pharmaceuticals

Explore 200,000+ acquisitions — free

Recent News related to Cubist Pharmaceuticals

FAQs about Cubist Pharmaceuticals

People who checked this page also checked these